Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain

被引：0

作者：

Terrés, CR

Rodríguez, J

Bolinder, B

de Pablos, P

机构：

[1] HERO Consulting Hlth Econ & Res Outcomes, Madrid, Spain

[2] Aventis Pharma, Bridgewater, NJ USA

[3] Univ Las Palmas de Gran Canaria, Las Palmas Gran Canaria, Spain

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

961

引用

页码：A345 / A345

页数：1

共 50 条

[1] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
Rodríguez, J
Terrés, CR
Bolinder, B
de Pablos, P
[J]. DIABETOLOGIA, 2004, 47 : A344 - A344
[2] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A291
[3] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A292
[4] Cost analysis of diabetes treatment with glargine insulin or NPH insulin in Spain
Rubio-Terrés, C
Rodriguez, J
Bolinder, B
[J]. VALUE IN HEALTH, 2003, 6 (03) : 336 - 336
[5] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[6] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
Home, PD
Rosskamp, R
Forjanic-Klapproth, J
Dressler, A
[J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
[7] Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes
Witthaus, E
Stewart, J
Bradley, C
[J]. DIABETIC MEDICINE, 2001, 18 (08) : 619 - 625
[8] Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: A systematic review
Hagenmeyer E.-G.
Koltermann K.C.
Dippel F.-W.
Schädlich P.K.
[J]. Cost Effectiveness and Resource Allocation, 9 (1)
[9] Economic impact of nocturnal hypoglycemia associated with the treatment of type 2 diabetes with insulin glargine or NPH insulin
Rubio-Terres, Carlos
Alvarez Guisasola, Fernando
Navarro Perez, Jorge
Delgado Alvarez, Elias
Azriel Mira, Sharona
Magana, Ana
[J]. AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 19 - 26
[10] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Moock, J.
Hessel, F.
Kohlmann, T.
[J]. VALUE IN HEALTH, 2008, 11 (06) : A514 - A514

← 1 2 3 4 5 →